Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered form

Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered form

US Patent 11033619 · Granted Jun 15, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for manufacturing a patient specific cell population using a multifunctio2025
Compositions and methods for treating cancer with DuoCARs2025
Adapter-based retroviral vector system for the selective transduction of target 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Sterile connector2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025